Clinical Trial Update: Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care [Phase 3]

View source ↗

Summary

Phase 3 trial updating on whether adding metformin to standard care after bariatric surgery extends the time without diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity-related Conditions

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Diabetes, Bariatric Surgery | Phase 3 | Status: RECRUITING